Form 8-K Summary
Registrant: GX Acquisition Corp. The provided filing does not identify Celularity Inc. as the registrant. Report date: May 24, 2019; earliest event reported May 20, 2019.
Business Context and Reporting Period
GX Acquisition Corp., a special purpose acquisition company, completed its initial public offering on May 23, 2019. The offering was intended to fund a future initial business combination. No operating business or revenue period is reported in this filing.
Key Financial and Capitalization Metrics
- IPO: 28,750,000 units sold at $10.00 per unit, generating gross proceeds of $287.5 million.
- Each unit included one share of Class A common stock and one-half of one redeemable warrant. Each whole warrant is exercisable for one share at $11.50.
- Private placement: 7,000,000 warrants sold to the sponsor at $1.00 per warrant, generating $7.0 million of gross proceeds.
- Trust account: $287.5 million deposited with J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company as trustee. The amount comprised $280.5 million of IPO proceeds, including a $2.0625 million deferred underwriting discount, and $7.0 million of private placement proceeds.
- The filing does not provide revenue, operating profit, net income, cash flow, margins, or debt balances.
Material Changes and Transactions
- The company entered into underwriting, warrant, sponsor, trust, registration rights, administrative support, and related agreements in connection with the IPO.
- The sponsor’s private placement warrants are generally restricted from transfer until 30 days after completion of the initial business combination and are not redeemable while held by the sponsor or permitted transferees.
- The company filed an amended and restated certificate of incorporation effective May 20, 2019.
Guidance, Outlook, Risks, and Unusual Items
- The trust funds generally cannot be released until completion of an initial business combination, an approved amendment triggering redemptions, or redemption of public shares if no business combination is completed within 24 months of the IPO closing.
- Interest earned on the trust account may be released for taxes, subject to up to $100,000 of interest for dissolution expenses.
- If the company does not complete a business combination within 24 months, public shares are subject to redemption, subject to applicable law.
- The filing contains no operating guidance or forecast.
Investor Verification Checklist
- Verify that the filing relates to GX Acquisition Corp., not Celularity Inc.
- Review the trust agreement and the 24-month deadline for completing a business combination.
- Assess dilution and potential overhang from the public and private placement warrants.
- Review the sponsor agreements, redemption provisions, and terms of the proposed business combination when announced.